Vikramaditya Dumpa,Puneet Gupta,Vaseem Iqbal et al.
Vikramaditya Dumpa et al.
Maria Gillam-Krakauer,Jeff Reese
Maria Gillam-Krakauer
Preterm infants are at increased risk for patent ductus arteriosus (PDA). Prolonged exposure to PDA may be deleterious and has been associated with neonatal morbidity and mortality. Although the molecular mechanisms underlying regulation of...
Payam Vali,Satyan Lakshminrusimha
Payam Vali
Monica S Arroyo,Ting Ting Fu,Robert B Hufnagel
Monica S Arroyo
The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension [0.03%]
新生儿肺动脉高压药物研发中生物标志物和替代终点的作用
Haihao Sun,Norman Stockbridge,Ronald L Ariagno et al.
Haihao Sun et al.
Pulmonary arterial hypertension (PAH) is a rare disease in newborns, infants, and children. It is associated with significant morbidity and mortality, but has limited treatment options. Except for inhaled nitric oxide, which is approved for...
Annette Wacker-Gussmann,Ronald T Wakai,Janette F Strasburger
Annette Wacker-Gussmann
Sudden, unexplained death during the perinatal period remains a major, longstanding challenge. Recent advances in diagnostic techniques and genetic testing has provided evidence that a significant fraction of these deaths may result from le...
Deepali Handa,Nancy Barclay,David Rehrauer et al.
Deepali Handa et al.
Satyan Lakshminrusimha,Martin Keszler
Satyan Lakshminrusimha
Persistent pulmonary hypertension of the newborn (PPHN) is often secondary to parenchymal lung disease (such as meconium aspiration syndrome) or lung hypoplasia (with congenital diaphragmatic hernia) but can also be idiopathic. PPHN is char...
Case 1: Infant With Intrauterine Growth Restriction, Dehydration, and Weight Loss [0.03%]
病例报告1：宫内生长受限合并脱水和体重下降的婴儿
Kaitlyn Phuong Le,Matthew B Wallenstein,Ian Chua
Kaitlyn Phuong Le
Case 1: Lactic Acidosis and Respiratory Distress in a 10-Day-Old Infant [0.03%]
病例报告1：10日龄婴儿乳酸性酸中毒和呼吸困难
Matthew B Wallenstein,Kaitlyn Olson,David M Peng et al.
Matthew B Wallenstein et al.